Nitric oxide inhibits the HIV-1 reverse transcriptase activity

被引:41
作者
Persichini, T
Colasanti, M
Fraziano, M
Colizzi, V
Medana, C
Polticelli, F
Venturini, G
Ascenzi, P
机构
[1] Unie Rome Tre, Dept Biol, I-00146 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[3] Univ Turin, Dept Pharmaceut Chem & Technol, I-10125 Turin, Italy
关键词
HIV-1 reverse transcriptase; nitric oxide; NO-donor; enzyme inhibition;
D O I
10.1006/bbrc.1999.0581
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) is a polypotent regulatory molecule involved in a variety of activities, such as the modulation of the catalytic activity of cysteine-containing enzymes. The present study reports the modulation of the HIV-1 reverse transcriptase activity by NO, released by the NO donors 3,3-bis(aminoethyl)-1-hydroxy-2-oxo-1-triazene (NOC-18), (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]5-nitro-3-hexenamide (NOR-3), 3-morpholinosydnonimine (SIN-1), 4-(phenylsulfonyl)-3-((2-(dimethylamino) ethyl)thio)furoxan oxalate (SNO-102), and sodium nitroprusside (SNP). NO inhibits dose-dependently the HIV-1 reverse transcriptase activity, Likely due to oxidation of Cys residue(s). Present results, representing a new insight into the modulation mechanism of the HIV-1 reverse transcriptase activity, may be relevant to develop new strategies for inhibition of HIV-1 replication. (C) 1999 Academic Press.
引用
收藏
页码:624 / 627
页数:4
相关论文
共 28 条
[1]   Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers [J].
Becker, K ;
Savvides, SN ;
Keese, M ;
Schirmer, RH ;
Karplus, PA .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) :267-271
[2]   LOSS OF ALPHA-TOCOPHEROL UPON EXPOSURE TO NITRIC-OXIDE OR THE SYDNONIMINE SIN-1 [J].
DEGROOT, H ;
HEGI, U ;
SIES, H .
FEBS LETTERS, 1993, 315 (02) :139-142
[3]   Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases [J].
Dimmeler, S ;
Haendeler, J ;
Nehls, M ;
Zeiher, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :601-607
[4]   MECHANISM OF INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS [J].
ESNOUF, R ;
REN, JS ;
ROSS, C ;
JONES, Y ;
STAMMERS, D ;
STUART, D .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (04) :303-308
[5]   HIV-1: Fifteen proteins and an RNA [J].
Frankel, AD ;
Young, JAT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :1-25
[6]   A NEW NITRIC-OXIDE (NO) RELEASER - SPONTANEOUS NO RELEASE FROM FK409 [J].
FUKUYAMA, S ;
KITA, Y ;
HIRASAWA, Y ;
SATO, A ;
MOROKOSHI, N ;
KODA, S ;
YASUDA, T ;
OKA, S ;
SAKURAI, H .
FREE RADICAL RESEARCH, 1995, 23 (05) :443-452
[7]   PROGRESS IN ANTI-HIV STRUCTURE-BASED DRUG DESIGN [J].
GAIT, MJ ;
KARN, J .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (10) :430-438
[8]   Loss of polymerase activity due to Tyr to Phe substitution in the YMDD motif of human immunodeficiency virus type-1 reverse transcriptase is compensated by Met to Val substitution within the same motif [J].
Harris, D ;
Yadav, PNS ;
Pandey, VN .
BIOCHEMISTRY, 1998, 37 (27) :9630-9640
[9]   NEW NITRIC OXIDE-RELEASING ZWITTERIONS DERIVED FROM POLYAMINES [J].
HRABIE, JA ;
KLOSE, JR ;
WINK, DA ;
KEEFER, LK .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (06) :1472-1476
[10]   Structure of a covalently trapped catalytic complex of HIV-I reverse transcriptase: Implications for drug resistance [J].
Huang, HF ;
Chopra, R ;
Verdine, GL ;
Harrison, SC .
SCIENCE, 1998, 282 (5394) :1669-1675